KRISTA JONES: Open Payments
NPI 1326470485 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 23 payments from 12 companies in 2025. Trend: 2023 $573 · 2024 $593 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $111 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| ABIOMED | 1 | $26 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $18 |
Products named: CAMZYOS, VERQUVO, AMVUTTRA, Assure WCD, Kerendia, NEXLETOL, ELIQUIS, REPATHA.
Industry payments across LA — which companies pay providers there.
